1-20 of 1981
herpesvirus 4, human
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD27 is required for protective lytic EBV antigen–specific CD8 + T-cell expansion

Yun Deng, Bithi Chatterjee, Kyra Zens, Hana Zdimerova, Anne Müller, Patrick Schuhmachers, Laure-Anne Ligeon, Antonino Bongiovanni, Riccarda Capaul, Andrea Zbinden, Angelika Holler, Hans Stauss, Wolfgang Hammerschmidt, Christian Münz
Journal: Blood
Blood (2021) 137 (23): 3225–3236.
https://doi.org/10.1182/blood.2020009482
Published: 2021
Includes: Supplemental data
Journal Articles

Mutational landscape of gray zone lymphoma

Clémentine Sarkozy, Stacy S. Hung, Elizabeth A. Chavez, Gerben Duns, Katsuyoshi Takata, Lauren C. Chong, Tomohiro Aoki, Aixiang Jiang, Tomoko Miyata-Takata, Adèle Telenius, Graham W. Slack, Thierry Jo Molina, Susana Ben-Neriah, Pedro Farinha, Peggy Dartigues, Diane Damotte, Anja Mottok, Gilles A. Salles, Rene-Olivier Casasnovas, Kerry J. Savage, Camille Laurent, David W. Scott, Alexandra Traverse-Glehen, Christian Steidl
Journal: Blood
Blood (2021) 137 (13): 1765–1776.
https://doi.org/10.1182/blood.2020007507
Published: 2021
Includes: Supplemental data
Journal Articles

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

M. K. Gandhi, T. Hoang, S. C. Law, S. Brosda, K. O’Rourke, J. W. D. Tobin, F. Vari, V. Murigneux, L. Fink, J. Gunawardana, C. Gould, H. Oey, K. Bednarska, S. Delecluse, R. U. Trappe, L. Merida de Long, M. B. Sabdia, G. Bhagat, G. Hapgood, E. Blyth, L. Clancy, J. Wight, E. Hawkes, L. M. Rimsza, A. Maguire, K. Bojarczuk, B. Chapuy, C. Keane
Journal: Blood
Blood (2021) 137 (11): 1468–1477.
https://doi.org/10.1182/blood.2020008520
Published: 2021
Includes: Supplemental data
Journal Articles

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

Clinical Trials & Observations
Juan C. Ramos, Joseph A. Sparano, Amy Chadburn, Erin G. Reid, Richard F. Ambinder, Eric R. Siegel, Page C. Moore, Paul G. Rubinstein, Christine M. Durand, Ethel Cesarman, David Aboulafia, Robert Baiocchi, Lee Ratner, Lawrence Kaplan, Adam A. Capoferri, Jeannette Y. Lee, Ronald Mitsuyasu, Ariela Noy
Journal: Blood
Blood (2020) 136 (11): 1284–1297.
https://doi.org/10.1182/blood.2019003959
Published: 2020
Includes: Supplemental data
Journal Articles

EBV-triggered hemophagocytic lymphohistiocytosis in a boy with a history of non-Hodgkin lymphoma

Clinical Trials & Observations
Michael H. Albert, Fabian Hauck
Journal: Blood
Blood (2020) 136 (5): 644.
https://doi.org/10.1182/blood.2020006580
Published: 2020
Journal Articles

EBV + diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant–related lymphomas

Clinical Trials & Observations
Lénaïg Mescam, Vincent Camus, Jean-Marc Schiano, José Adélaïde, Jean-Michel Picquenot, Arnaud Guille, Marie Bannier, Philippe Ruminy, Pierre-Julien Viailly, Fabrice Jardin, Reda Bouabdallah, Isabelle Brenot-Rossi, Elodie Bohers, Cyrielle Robe, Camille Laurent, Daniel Birnbaum, Andrew Wotherspoon, Philippe Gaulard, Luc Xerri
Journal: Blood
Blood (2020) 135 (22): 2004–2009.
https://doi.org/10.1182/blood.2019003408
Published: 2020
Includes: Supplemental data
Journal Articles

Sensitizing Burkitt lymphoma to EBV-CTLs

Helen E. Heslop
Journal: Blood
Blood (2020) 135 (21): 1822–1823.
https://doi.org/10.1182/blood.2020005492
Published: 2020
Journal Articles

Epigenetic reprogramming sensitizes immunologically silent EBV + lymphomas to virus-directed immunotherapy

Tanner Dalton, Ekaterina Doubrovina, Dmitry Pankov, Raymond Reynolds, Hanna Scholze, Annamalai Selvakumar, Teresa Vizconde, Bhumesh Savalia, Vadim Dyomin, Christoph Weigel, Christopher C. Oakes, Alicia Alonso, Olivier Elemento, Heng Pan, Jude M. Phillip, Richard J. O’Reilly, Benjamin E. Gewurz, Ethel Cesarman, Lisa Giulino-Roth
Journal: Blood
Blood (2020) 135 (21): 1870–1881.
https://doi.org/10.1182/blood.2019004126
Published: 2020
Includes: Supplemental data
Journal Articles

Pediatric hemophagocytic lymphohistiocytosis

Scott W. Canna, Rebecca A. Marsh
Journal: Blood
Blood (2020) 135 (16): 1332–1343.
https://doi.org/10.1182/blood.2019000936
Published: 2020
Journal Articles

Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder

Christopher Melani, Elaine S. Jaffe, Wyndham H. Wilson
Journal: Blood
Blood (2020) 135 (16): 1344–1352.
https://doi.org/10.1182/blood.2019000933
Published: 2020
Journal Articles

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults

Clinical Trials & Observations
Pengpeng Liu, Xiangyu Pan, Chong Chen, Ting Niu, Xiao Shuai, Jian Wang, Xuelan Chen, Jiazhuo Liu, Yong Guo, Liping Xie, Yu Wu, Yu Liu, Ting Liu
Journal: Blood
Blood (2020) 135 (11): 826–833.
https://doi.org/10.1182/blood.2019003886
Published: 2020
Includes: Supplemental data
Journal Articles

Checkmate for EBV-HLH

Nader Kim El-Mallawany, Kenneth L. McClain
Journal: Blood
Blood (2020) 135 (11): 782–784.
https://doi.org/10.1182/blood.2020005041
Published: 2020
Journal Articles

Virus-specific T-cell therapies for patients with primary immune deficiency

Clinical Trials & Observations
Michael D. Keller, Catherine M. Bollard
Journal: Blood
Blood (2020) 135 (9): 620–628.
https://doi.org/10.1182/blood.2019000924
Published: 2020
Journal Articles

Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection

Stuart G. Tangye, Sylvain Latour
Journal: Blood
Blood (2020) 135 (9): 644–655.
https://doi.org/10.1182/blood.2019000928
Published: 2020
Journal Articles

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Alexandre S. Cristino, Jamie Nourse, Rachael A. West, Muhammed Bilal Sabdia, Soi C. Law, Jay Gunawardana, Frank Vari, Sally Mujaj, Gayathri Thillaiyampalam, Cameron Snell, Madeline Gough, Colm Keane, Maher K. Gandhi
Journal: Blood
Blood (2019) 134 (25): 2261–2270.
https://doi.org/10.1182/blood.2019000889
Published: 2019
Includes: Supplemental data
Journal Articles

Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen

Xinhua Wang, MD PhD, Lei Zhang, Xiangli Liu, Xin Li, Ling Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Jiaqin Yan, Yu Chang, Feifei Nan, Zhiyuan Zhou, Xiaolong Wu, Li Tian, Wencai Li, Hongwei Xue, Jinghua Wang, Liqun Zou, Liping Su, Yi Lu, Yanzhen Guo, Ken H. Young, Mingzhi Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 463.
https://doi.org/10.1182/blood-2019-127811
Published: 2019
Journal Articles

Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study

Pierluigi Porcu, MD, Brad M. Haverkos, MDMPH,MS, Onder Alpdogan, MD, Marcelo Capra, MD PhD, Tatyana A. Feldman, MD, Elizabeth Brem, MD, Anusha Vallurupalli, MD, Jonathan E. Brammer, MD, Ana Schriefer, Juliana Pereira, MD PhD, Anil Tulpule, MD, Stefan K. Barta, MD MRCP, MS, Locke J. Bryan, MD, Richard Trauger, Sebastian Obrzut, John Gutheil, MD, Afton Katkov, MSc, Robert McRae, Ivor Royston, MD, Douglas V. Faller, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 465.
https://doi.org/10.1182/blood-2019-132004
Published: 2019
Journal Articles

Transcriptomic Analysis of CD4+ T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28:CD80/86 Costimulation Blockade with Abatacept

Benjamin Watkins, Yvonne Suessmuth, Kayla Betz, BS, Alison Yu, PhD, Brandi Bratrude, Muna Qayed, MD MSc, Kathryn Pellegrini, Steven Bosinger, Amelia Langston, MD, John T. Horan, MDMPH, Bruce R. Blazar, MD, Leslie Kean, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 596.
https://doi.org/10.1182/blood-2019-131955
Published: 2019
Journal Articles

Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

Tomohiro Aoki, MD PhD, Lauren C. Chong, MSc, Katsuyoshi Takata, MD PhD, Katy Milne, Monirath Hav, PhD, Anthony Colombo, MS, Elizabeth Chavez, BSc, Cg RT, Tomoko Miyata-Takata, Vivian Lam, Chanel Ghesquiere, Daniel Kos, Talia Goodyear, Allen W. Zhang, Xuehai Wang, PhD, Saeed Saberi, Jiarui W. Ding, Pedro Farinha, MD PhD, Andrew P. Weng, MD PhD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD, Gerald Krystal, PhD, Brad H. Nelson, Anja Mottok, MD PhD, Akil Merchant, MD, Sohrab P Shah, Christian Steidl, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 547.
https://doi.org/10.1182/blood-2019-121584
Published: 2019
Journal Articles

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Ethel Cesarman, MD PhD, Mikhail Roshal, MD PhD, Jonathan Reichel, PhD, Wagner Florian, PhD, Bhavneet Binder, Sakellarios Zairis, Jouliana Sadek, PhD, Joshua Brody, MD, Raul Rabadan, PhD, Sandeep Dave, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 549.
https://doi.org/10.1182/blood-2019-131163
Published: 2019